健脾生血颗粒治疗老年人缺铁性贫血临床观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

武汉市科技攻关计划(编号:2013070204020053)


Clinical Observation on Jianpi Shengxue Granule in the Treatment of Elderly Patients with Iron Deficiency Anemia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察健脾生血颗粒治疗老年人缺铁性贫血的临床疗效及作用机制。方法:将80例符合缺铁性贫血的老年患者随机分为2组。对照组32例,给予福乃得口服治疗。治疗组48例,给予健脾生血颗粒口服。2组连续治疗30 d后观察有效率及RBC、Hb、MCV、MCH、MCHC、血清铁、总铁结合力指标变化。结果:治疗组临床总有效率明显高于对照组(P<0.05)。2组治疗后RBC、Hb、MCV、MCH、MCHC、血清铁、总铁结合力均有显著改善,但2组治疗后指标比较无统计学意义(P>0.05)。结论:健脾生血颗粒治疗老年人缺铁性贫血疗效显著,值得临床推广应用。

    Abstract:

    To observe the clinical effect and the mechanism of Jianpi Shengxue Granule in the treatment of elderly patients with iron deficiency anemia. Methods:Eighty elderly patients with iron deficiency anemia who meet with inclusive criteria were selected and randomly divided into two groups, namely the control group (32 patients) with Funaide oral liquid and the treatment group (48 patients) with Jianpi Shengxue Granule. The efficacy was observed after 30 days in two groups. Results:The total effective rate of treatment group was better than that of control group (P<0.05). The RBC, Hb, MCV, MCH, MCHC, serum iron and TIBC were obviously improved after the treatment compared with those before treatment (P<0.05) but without significant difference between the two groups after treatment (P>0.05). Conclusion:Jianpi Shengxue Granule may have good cure effect on iron deficiency anemia in elderly patients and it is worthy of clinical use.

    参考文献
    相似文献
    引证文献
引用本文

宋恩峰,张彩蝶,梅莎莎,裴学军,肖飞.健脾生血颗粒治疗老年人缺铁性贫血临床观察[J].世界中医药,2016,(05).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-03-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2016-05-18
  • 出版日期:
文章二维码